Levcromakalim may induce a voltage‐independent K‐current in rat portal veins by modifying the gating properties of the delayed rectifier
Open Access
- 1 November 1993
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (3) , 1037-1048
- https://doi.org/10.1111/j.1476-5381.1993.tb13918.x
Abstract
1 Smooth muscle cells of the rat portal vein were dispersed by enzymatic treatment and recordings of whole‐cell currents under calcium‐free conditions were made by the voltage‐clamp technique. The effects of the potassium (K)‐channel opener, levcromakalim, on K‐currents were compared with those of agents which modify protein phosphorylation. 2 Levcromakalim (1–10 μm) added to the extracellular (bath) fluid caused the development of a non‐inactivating current (IK(ATP)) and simultaneously inhibited the delayed rectifier current (IK(V)) in a concentration‐dependent manner. On prolonged exposure to levcromakalim (10 μm), IK(ATP) declined and IK(V) was further diminished. 3 Addition to the pipette (intracellular) solution of the selective inhibitor of protein kinase C, calphostin C, itself had no effect on K‐currents and did not modify the induction of IK(ATP) or the simultaneous inhibition of IK(V) produced by 1 μm levcromakalim. 4 Addition of the protein kinase inhibitor (PKI(6–22)amide, 1 μm) to the pipette solution caused the production of a glibenclamide‐sensitive, non‐inactivating current and inhibited IK(V). 5 In an assay system, levcromakalim (10 μm) did not inhibit the activity of purified protein kinase A (Type 1 or Type 2). 6 Addition to the pipette solution of the phosphatase inhibitor, okadaic acid (1 μm), did not itself modify K‐currents and had little effect on the simultaneous induction of IK(ATP) and inhibition of IK(V) by levcromakalim (1 μm). 7 When the pipette solution contained 1 mm MgATP (but was depleted of substrates for ATP production), a non‐inactivating, glibenclamide‐sensitive K‐current developed spontaneously in 5 out of 11 cells with the simultaneous reduction of IK(V). In 3 of the 6 remaining cells, addition of the dephosphorylating agent, butanedione monoxime (5 mm) to the bath inhibited IK(V) and stimulated a glibenclamide‐sensitive non‐inactivating current. 8 Depletion of intracellular Mg2+ slightly enhanced IK(V). Under these conditions, levcromakalim (1 μm and 10 μm) did not significantly induce IK(ATP) or inhibit IK(v). 9 It is concluded that the effects of levcromakalim on K‐currents can be mimicked by procedures designed to reduce channel phosphorylation. The results are consistent with the view that levcromakalim dephosphorylates the delayed rectifier channel, Kv, which becomes converted into a voltage‐independent, non‐inactivating form known as KATP. The possible mechanisms which underlie this interconversion are discussed.Keywords
This publication has 57 references indexed in Scilit:
- The Pharmacology of ATP-Sensitive Potassium ChannelsAnnual Review of Pharmacology and Toxicology, 1993
- Protein kinase C of smooth muscle.Hypertension, 1992
- Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents.The Journal of general physiology, 1992
- Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivityJournal of Medicinal Chemistry, 1992
- Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylationNature, 1991
- Cyclic nucleotide-dependent protein kinasesPharmacology & Therapeutics, 1991
- Phosphorylation affects voltage gating of the delayed rectifier K+ channel by electrostatic interactionsNeuron, 1990
- THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASESAnnual Review of Biochemistry, 1989
- Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1989
- Adenosine 5'-Triphosphate-Sensitive Potassium ChannelsAnnual Review of Neuroscience, 1988